Jabir Abdur Rahman, Zaheer Haniah A, Zaheer Myra A, Zaheer Eesha A, Birdsong Richard
School of Medicine, Northeast Ohio Medical University, Rootstown, USA.
School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
Cureus. 2022 Oct 8;14(10):e30074. doi: 10.7759/cureus.30074. eCollection 2022 Oct.
Retinoblastoma (RB) is a common intraocular cancer in pediatric patients worldwide, and screening is routinely performed throughout the first few years of life. The diagnosis is often made clinically; however, the diagnosis can be delayed due to undetectable leukocoria because of small tumor size at the time of examination, missed appointments, non-compliance with eye examinations, or failure to perform the exam. As mobile devices continue to gain in both popularity and functionality, their use via applications and smartphone attachments for ocular examination introduces a new avenue for screening, detection, and staging of RB both inside and outside the clinical setting. Currently, research regarding mobile device use is still in its infancy, and further research is required to determine whether mobile devices could play a significant role in assisting with the diagnosis of RB. The purpose of this systematic review was to determine whether the existing literature supports the use of mobile devices by healthcare providers, specifically ophthalmologists and non-ophthalmologists, as well as by parents for the early detection of RB. A comprehensive literature search was conducted via PubMed, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science with a total of 10 studies included in the final analysis.
视网膜母细胞瘤（RB）是全球儿科患者中常见的眼内癌，在生命的最初几年通常会进行筛查。诊断通常通过临床手段进行；然而，由于检查时肿瘤较小导致白瞳症无法检测到、错过预约、不遵守眼部检查或未能进行检查等原因，诊断可能会延迟。随着移动设备的普及和功能不断增强，通过应用程序和智能手机附件进行眼部检查为临床内外的RB筛查、检测和分期开辟了一条新途径。目前，关于移动设备使用的研究仍处于起步阶段，需要进一步研究以确定移动设备是否能在协助RB诊断方面发挥重要作用。本系统评价的目的是确定现有文献是否支持医疗保健提供者，特别是眼科医生和非眼科医生以及家长使用移动设备早期检测RB。通过PubMed、护理及相关健康文献累积索引（CINAHL）和科学网进行了全面的文献检索，最终分析共纳入10项研究。
